Hypochlorous Acid - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The hypochlorous acid market size was valued at USD 5.93 billion in 2025 and is estimated to grow from USD 6.25 billion in 2026 to reach USD 8.15 billion by 2031, at a CAGR of 5.45% during the forecast period (2026-2031). This report is segmented by Product Type (Sodium Hypochlorite, Calcium Hypochlorite, and More), Application (Disinfecting Agent, Surface and Equipment Disinfection, and More), End-Use Industry (Water Treatment, Food and Beverage, and More), and Geography (Asia-Pacific, North America, Europe, South America, and Middle East and Africa). The Market Forecasts are Provided in Terms of Value (USD).

Global Hypochlorous Acid Market Trends and Insights

Demand for Safer, Low-Residue Disinfection

Institutional and consumer buyers are reassessing disinfectant portfolios for residue toxicity, environmental persistence, and human safety. Hypochlorous acid degrades to a dilute saline solution after use, which supports use in food processing and pediatric healthcare settings. The World Health Organization review published in 2025 found strong in vitro bactericidal activity for hypochlorous acid among chlorine-based compounds and reported no observed toxicity to mammalian cells in the evidence reviewed for wound care. The review also compared its safety and antimicrobial evidence favorably with povidone-iodine for wound care. Procurement teams can use this evidence when considering a switch from legacy biocides, which can shorten the path from testing to wider use in the hypochlorous acid market. The same safety profile is relevant when facilities must balance cleaning performance with worker exposure, product residue, and the need to use a solution on frequently touched surfaces.

Expansion of Healthcare-Associated Infection Control

The United States recorded an estimated 518,000 healthcare-associated infections in acute-care hospitals in 2023, affecting one in 38 hospitalized patients on a given day. Surgical site infection rates moved unfavorably in 2024, which renewed attention to hospital disinfection procedures. Hypochlorous acid is used in clinical settings where organizations need solutions that are effective against drug-resistant pathogens and tolerated on sensitive surfaces. The World Health Organization's global action plan for infection prevention and control for 2024 to 2030 calls for investment in programs that prevent healthcare-associated infection. Wound irrigation creates a separate clinical opportunity for producers with stabilized formulations and the regulatory support needed for medical claims. This use requires clinical evidence and product consistency, which separates medical-oriented suppliers from producers focused only on general cleaning applications.

Concentration and Shelf-Life Sensitivity

Hypochlorous acid becomes less stable when formulations use conditions that maximize antimicrobial performance. Exposure to ultraviolet light, elevated temperature, pH variation, and organic contamination can reduce concentration and usable shelf life. This creates cold chain needs and makes bulk shipments to humid or tropical locations harder to manage. Commission Implementing Regulation (EU) 2025/831 required a long-term storage stability test as a post-authorization commitment for the authorized calcium hypochlorite product family. Stabilization methods, including nanobubble infusion, buffered pH management, and chelant addition, therefore, remain central areas of competition in the hypochlorous acid market. Customers who cannot store large quantities may need smaller and more frequent deliveries, which can increase unit costs while limiting opportunities for large-volume contracts.

Other drivers and restraints analyzed in the detailed report include:

• Growth of Municipal and Industrial Water Reuse
• Food-Safety and Fresh-Produce Sanitization Requirements
• Fragmented, Claim-Specific Regulatory Classification

Segment Analysis

Sodium hypochlorite held 54.67% of the hypochlorous acid market share in 2025, supported by its established role in municipal water treatment, household bleach, and institutional cleaning. Utilities and food processors have invested in equipment designed for hypochlorite dosing, monitoring, and residual measurement. Those systems make a switch to another chemistry more difficult for large operators. Calcium hypochlorite is projected to advance at a 6.56% CAGR through 2031 because it offers greater ambient-temperature stability and suits recreational water treatment, point-of-use tablets, and agricultural disinfection.

Other product types include stabilized hypochlorous acid solutions with pH levels of 6.5 to 7.5, electrolyzed-water formulations, and ready-to-use sprays. These formats serve clinical wound care and premium consumer personal care, where differentiation can support better margins. Overcapacity in chlor-alkali manufacturing has intensified price competition for undifferentiated liquid sodium hypochlorite. The European Commission granted Union Authorization for the AWPF Calcium Hypochlorite Biocidal Product Family in May 2025, which clarified access conditions for calcium hypochlorite products across the European Union. The hypochlorous acid industry is, therefore, divided between high-volume commodity products and specialized formats that can earn a unit-price premium. Calcium hypochlorite offers a practical option where liquid handling is difficult, while stabilized formats serve use cases that place greater value on shelf life, safety, and clinical support.

Complete Report Scope:

• By Product Type
  • Sodium Hypochlorite
  • Calcium Hypochlorite
  • Other Product Types
• By Application
  • Disinfecting Agent
  • Sanitizing Agent
  • Oxidizing Agent
  • Wound Care and Skin Cleansing
  • Surface and Equipment Disinfection
  • Other Applications
• By End-Use Industry
  • Water Treatment
  • Healthcare and Wound Management
  • Food and Beverage
  • Agriculture and Horticulture
  • Residential, Commercial and Industrial Cleaning
  • Other End-Use Industries
• By Geography
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • ASEAN Countries
    • Rest of Asia-Pacific
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • NORDIC Countries
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East and Africa

Geography Analysis

North America held 37.06% of the hypochlorous acid market share in 2025, supported by water treatment infrastructure, hospital disinfection procurement, and food, wound-care, and surface-disinfection applications. The United States Environmental Protection Agency List N registration provided a recognized purchasing criterion for emerging pathogen control. This helped hospitals and food processors evaluate hypochlorous acid products against their disinfection requirements. Canada's Biocides Regulations entered into force on May 31, 2025, and require a transition to the new authorization system for affected surface disinfectant products. Sonoma Pharmaceuticals, Inc. operates a Guadalajara facility that supports distribution in more than 55 countries, showing the role of Mexico in regional production and export supply.

Asia-Pacific is projected to advance at a 5.89% CAGR through 2031. Growth is tied to municipal water disinfection in urbanizing secondary cities, food-processing export requirements, and clinical wound care. Japan has a multi-channel regulatory structure that supports food, healthcare, and agricultural use. The Ministry of Agriculture, Forestry, and Fisheries updated the organic standard in July 2024, while food safety authorities have assessed hypochlorous acid water for food use. South Korea and Association of Southeast Asian Nations countries are at an earlier adoption stage, with food exports and hospital infection control serving as key demand anchors.

In Europe, Germany, the United Kingdom, and Nordic countries show strong institutional and industrial cleaning use. Regulation (EU) 528/2012 governs biocidal product authorization, while Regulation (EU) 2025/831 established a Union-level compliance benchmark for the authorized calcium hypochlorite family. Briotech expanded product availability in Finland, the Netherlands, Sweden, Germany, and France in 2025. South America and Middle East and Africa remain earlier-stage areas where water treatment and healthcare investment support demand. High temperatures and limited storage infrastructure constrain adoption in several Middle East and African locations.

List of Companies Covered in this Report:

• AQUALUTION
• Aquaox LLC
• BACTIGUARD AB
• Briotech
• EcoloxTech, Inc.
• Envirolyte Industries International Ltd.
• Esteripharma S.A. de C.V.
• Force of Nature
• Kersia Group
• Ozo Innovations
• PureAquaox
• Simple Science LLC
• Sonoma Pharmaceuticals, Inc.
• The Clorox Company
• UltraPure

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support